Total Payments
$91,314
2024 Payments
$68,900
Companies
44
Transactions
1,356
Medicare Patients
4,859
Medicare Billing
$2.6M
Payment Breakdown by Category
Research$62,482 (68.4%)
Food & Beverage$24,647 (27.0%)
Consulting$2,160 (2.4%)
Travel$1,710 (1.9%)
Education$314.23 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $62,482 | 2 | 68.4% |
| Food and Beverage | $24,647 | 1,344 | 27.0% |
| Consulting Fee | $2,160 | 1 | 2.4% |
| Travel and Lodging | $1,710 | 2 | 1.9% |
| Education | $314.23 | 7 | 0.3% |
Payments by Type
Research
$62,482
2 transactions
General
$28,831
1,354 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $62,482 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $6,043 | 110 | $0 (2024) |
| Amgen Inc. | $4,554 | 216 | $0 (2024) |
| ABBVIE INC. | $3,447 | 189 | $0 (2024) |
| UCB, Inc. | $1,766 | 87 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $1,718 | 138 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,253 | 95 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,249 | 71 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,224 | 52 | $0 (2024) |
| PFIZER INC. | $992.93 | 70 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $68,900 | 212 | Eli Lilly and Company ($62,482) |
| 2023 | $4,327 | 220 | Aurinia Pharma U.S., Inc. ($775.57) |
| 2022 | $3,626 | 188 | ABBVIE INC. ($834.58) |
| 2021 | $2,021 | 112 | Janssen Biotech, Inc. ($533.75) |
| 2020 | $1,823 | 102 | Amgen Inc. ($549.69) |
| 2019 | $2,889 | 184 | Amgen Inc. ($886.80) |
| 2018 | $3,243 | 160 | Amgen Inc. ($451.53) |
| 2017 | $4,485 | 178 | Janssen Biotech, Inc. ($1,722) |
All Payment Transactions
1,356 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| Category: Immunology | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 12/06/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/04/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Eli Lilly and Company | TALTZ (Drug) | — | Cash or cash equivalent | $60,130.00 | Research |
| Study: EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH ACTIVE PSORIATIC ARTHRITIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSA) • Category: Immunology | ||||||
| 11/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $0.89 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $14.56 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Immunology | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/12/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.48 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH ACTIVE PSORIATIC ARTHRITIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSA) | Eli Lilly and Company | $62,482 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,375 | 115,739 | $3.1M | $741,361 |
| 2022 | 18 | 1,064 | 107,863 | $2.3M | $613,986 |
| 2021 | 18 | 1,085 | 111,253 | $2.1M | $738,360 |
| 2020 | 25 | 1,335 | 68,417 | $1.3M | $498,878 |
Total Patients
4,859
Total Services
403,272
Medicare Billing
$2.6M
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 23 | 82,000 | $1.5M | $302,028 | 20.5% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 21 | 11,763 | $529,335 | $111,278 | 21.0% |
| J3111 | Injection, romosozumab-aqqg, 1 mg | Office | 2023 | 12 | 13,230 | $357,210 | $105,764 | 29.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 320 | 875 | $161,000 | $76,209 | 47.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 30 | 2,940 | $185,220 | $51,809 | 28.0% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 61 | 577 | $134,441 | $30,222 | 22.5% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 92 | 256 | $48,573 | $16,567 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 137 | 137 | $38,360 | $15,163 | 39.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 37 | 114 | $47,880 | $10,534 | 22.0% |
| 20526 | Injection of carpal tunnel | Office | 2023 | 30 | 42 | $10,038 | $3,059 | 30.5% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 40 | 59 | $5,959 | $2,579 | 43.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 183 | 2,883 | $11,532 | $2,295 | 19.9% |
| 20606 | Aspiration and/or injection of fluid from medium joint using ultrasound guidance | Office | 2023 | 21 | 33 | $8,646 | $2,219 | 25.7% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 33 | 103 | $9,476 | $2,102 | 22.2% |
| 20604 | Aspiration and/or injection of fluid from small joint using ultrasound guidance | Office | 2023 | 16 | 26 | $6,240 | $1,607 | 25.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 115 | 173 | $7,439 | $1,583 | 21.3% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 19 | 30 | $5,040 | $1,248 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $1,984 | $964.05 | 48.6% |
| 76882 | Limited ultrasound scan of joint or other extremity structure except blood vessels | Office | 2023 | 15 | 30 | $2,940 | $909.16 | 30.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 16 | $3,040 | $860.14 | 28.3% |
| 96361 | Infusion into a vein for hydration, each additional hour | Office | 2023 | 30 | 83 | $4,150 | $753.48 | 18.2% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 11 | 15 | $1,425 | $565.92 | 39.7% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 11 | 46 | $2,208 | $537.74 | 24.4% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 34 | 104 | $1,872 | $411.48 | 22.0% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 30 | 84 | $1,764 | $40.05 | 2.3% |
About Dr. Eric Chiang, MD
Dr. Eric Chiang, MD is a Rheumatology healthcare provider based in Corpus Christi, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2010. The National Provider Identifier (NPI) number assigned to this provider is 1386962116.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Chiang, MD has received a total of $91,314 in payments from pharmaceutical and medical device companies, with $68,900 received in 2024. These payments were reported across 1,356 transactions from 44 companies. The most common payment nature is "" ($62,482).
As a Medicare-enrolled provider, Chiang has provided services to 4,859 Medicare beneficiaries, totaling 403,272 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Corpus Christi, TX
- Active Since 05/04/2010
- Last Updated 03/18/2025
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1386962116
Products in Payments
- TALTZ (Drug) $60,869
- TREMFYA (Drug) $3,664
- Enbrel (Biological) $2,761
- SIMPONI ARIA (Biological) $1,964
- LUPKYNIS (Drug) $1,718
- RINVOQ (Biological) $1,709
- Cimzia (Drug) $1,579
- ORENCIA (Biological) $1,253
- SAPHNELO (Biological) $1,201
- ACTHAR (Biological) $1,036
- COSENTYX (Biological) $784.21
- XELJANZ (Drug) $761.15
- Humira (Biological) $606.69
- SKYRIZI (Biological) $546.51
- BENLYSTA (Biological) $511.19
- EVENITY (Biological) $466.58
- COSENTYX (Drug) $415.52
- KRYSTEXXA (Biological) $401.73
- REMICADE (Biological) $383.25
- Prolia (Biological) $365.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Corpus Christi
Dr. Ann Aleman Weinmann, Md, MD
Rheumatology — Payments: $19,579
Rheumatology $19,579
Cindy Rodriguez-Silva, Md, MD
Rheumatology — Payments: $3,616
Rheumatology $3,616
Francisco Brito-Aleman, Md, MD
Rheumatology — Payments: $1,806
Rheumatology $1,806
Marie Impe, Np, NP
Rheumatology — Payments: $291.23
Rheumatology $291.23
Frank Morgan, Md, MD
Rheumatology
Rheumatology